Holen Sie sich die Stockscreener-App
0.0006
0.00%
0.00
T 2 Biosystems Inc Aktie (TTOO) Neueste Nachrichten
Tonix Pharmaceuticals Holding Corp. (TNXP) stock price, news, quote and history - Yahoo Finance Singapore
T2 Biosystems, Inc. Revenue Breakdown – OTC:TTOO - TradingView
T2 Biosystems, Inc. Revenue Breakdown – LS:A3EU63 - TradingView
Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026 - Yahoo! Finance Canada
TTOO Price History for T2 Biosystems CS Stock - Barchart.com
Lyme Disease Testing Market Analysis Highlights Growth To $16.46 Billion By 2030 At 9% CAGR - openPR.com
Imagion Biosystems, Siemens Healthineers Extend Imaging Agent Collaboration - Imaging Technology News
Price to sales forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Price to earnings forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Enterprise value to revenue forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Price to book forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems, Inc. Actuals & Estimates (OTC:TTOO) - TradingView
T2 Biosystems, Inc. Actuals & Estimates (LSE:0A57) - TradingView
Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial - Business Wire
Lyme Disease Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Abbott, Bio-Rad Labs, Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Barchart.com
BioSystems Engineering (01355) plans to conduct a rights issue on a "2-for-1" basis, aiming to raise up to approximately HK$39 million in net proceeds. - Moomoo
Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD - BioSpace
Rapid Carbapenem-Resistant Organism Identification Market Growth to Accelerate by 2035 Driven by Multiplex Syndromic PanelsNews and Statistics - IndexBox
Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review - Medianet News Hub
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering - Yahoo Finance
T2 Biosystems Inc (OTCM:TTOO) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
T2 Biosystems Inc (OTCM:TTOO) Stock Earnings Transcripts - GuruFocus
T2 Biosystems Inc (OTCM:TTOO) Stock Price & 30 Year Financial Data - GuruFocus
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Number of shareholders of T2 Biosystems, Inc. – OTC:TTOO - TradingView
VBIO Stock Price and Chart — NASDAQ:VBIO - TradingView
Leica Biosystems unveils next-generation digital pathology scanner and AI-powered QC software - Drug Discovery News
Financial Analysis: Biostage (OTCMKTS:BSTG) and T2 Biosystems (NASDAQ:TTOO) - defenseworld.net
T2 Biosystems (NASDAQ:TTOO) Stock Passes Below 200-Day Moving Average – Time to Sell? - Defense World
Aspect Biosystems secures $79-million in federal funding to advance 3-D tissue printing technology - The Globe and Mail
TTOO (T2 Biosystems) PB Ratio : (As of Mar. 27, 2026) - GuruFocus
TTOO stock $0.0001 on NASDAQ 19 Mar 2026 Market Closed: top losers risk - Meyka
T2 Biosystems2026 Funding Rounds & List of Investors - Tracxn
RBOT Stock Price and Chart — OTC:RBOT - TradingView
T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations - marketscreener.com
TTOO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
New hires at Rapid Micro Biosystems get 205K RSUs, 168K options - Stock Titan
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent - BioSpace
Targeted Imaging Agent Submitted to FDA for IND Application - Imaging Technology News
TTOO Stock Price and Chart — OTC:TTOO - TradingView
Aspect Biosystems expands partnership with Novo Nordisk to develop diabetes treatment - The Globe and Mail
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - simplywall.st
T2 Biosystems (TTOO) Earnings Calendar_Earnings Analysis_Financial Report and Earnings Call - Tiger Brokers
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) last week's 10% decline must have disappointed private equity firms who have a significant stake - simplywall.st
Ocean Dx sepsis test matches gold standard in early study - BioWorld News
DHAI Stock Price and Chart — OTC:DHAI - TradingView
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
NAVBQ Stock Price and Chart — OTC:NAVBQ - TradingView
Imagion Biosystems (ASX:IBX) gets ready for Phase 2 - Stocks Down Under
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - Yahoo Finance UK
[25-NSE] T2 BIOSYSTEMS INC SEC Filing - Stock Titan
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
T2 Biosystems (TTOO) Stock Price, News & Analysis - Stock Titan
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025 - The Business Journals
T2 BIOSYSTEMS INCMATURITY DATE EXTENDED TO MARCH 31, 2026 - Moomoo
T2 Biosystems initiates major layoffs, seeks asset sale By Investing.com - Investing.com Australia
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Massachusetts-based medical diagnostics firm lays off ‘substantially all' employees - NBC Boston
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems to be delisted from Nasdaq - Investing.com
Cytrellis Biosystems launches Updated Next-Generation Skin - GlobeNewswire
Competition ticks up to reset the clock for sepsis - BioWorld News
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems stock plunges to 52-week low of $0.41 - Investing.com
T2 Biosystems Announces Licensing Plans to Enhance Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - Quiver Quantitative
T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com UK
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Reven - GuruFocus
T2 Biosystems stock plunges to 52-week low of $0.55 - Investing.com
T2 Biosystems Forges Sales Deal With Cardinal Health for Sepsis Test - Medical Product Outsourcing
1.06%
Kapitalisierung:
|
Volumen (24h):